HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Riccardo Candido Selected Research
Riccardo Candido Research Topics
Disease
22
Type 2 Diabetes Mellitus (MODY)
05/2024 - 04/2004
9
Albuminuria
03/2024 - 05/2002
8
Atherosclerosis
03/2011 - 07/2002
7
Hyperglycemia
11/2023 - 11/2005
7
Hypoglycemia (Reactive Hypoglycemia)
11/2023 - 01/2014
5
Diabetes Mellitus
06/2018 - 10/2006
5
Hypertension (High Blood Pressure)
06/2005 - 03/2002
4
Heart Failure
01/2023 - 01/2010
3
Body Weight (Weight, Body)
03/2024 - 01/2018
3
Inflammation (Inflammations)
04/2013 - 11/2009
2
Cardiovascular Diseases (Cardiovascular Disease)
06/2023 - 05/2013
2
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021 - 04/2017
2
Chronic Renal Insufficiency
02/2019 - 07/2017
2
Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2014 - 04/2013
2
Diabetic Nephropathies (Diabetic Nephropathy)
01/2014 - 03/2002
2
Fibrosis (Cirrhosis)
04/2013 - 10/2005
2
Proteinuria
07/2002 - 05/2002
1
Neoplasms (Cancer)
04/2024
1
Sudden Infant Death (SID)
04/2024
1
Weight Gain
01/2023
1
Gestational Diabetes (Gestational Diabetes Mellitus)
01/2022
1
Acute Coronary Syndrome
06/2019
1
Nephrogenic Fibrosing Dermopathy
02/2019
1
Hypertrophy
03/2015
1
Chronic Kidney Failure (Chronic Renal Failure)
01/2014
1
Obesity
05/2013
1
Frailty
05/2013
1
Hepatocellular Carcinoma (Hepatoma)
04/2013
1
Overweight
04/2013
1
Necrosis
11/2012
1
Cardiomyopathies (Cardiomyopathy)
06/2012
1
Coronary Artery Disease (Coronary Atherosclerosis)
01/2010
1
Atherosclerotic Plaque (Atheroma)
10/2006
1
Diabetic Angiopathies (Diabetic Angiopathy)
10/2006
1
Hyperlipidemias (Hyperlipidemia)
11/2005
Drug/Important Bio-Agent (IBA)
9
Insulin (Novolin)
FDA Link
05/2024 - 05/2013
8
Glucose (Dextrose)
FDA Link
Generic
03/2024 - 06/2019
6
Apolipoproteins E (ApoE)
IBA
06/2012 - 07/2004
4
Blood Glucose (Blood Sugar)
IBA
03/2024 - 01/2014
4
Osteoprotegerin
IBA
07/2017 - 12/2006
4
Collagen
IBA
10/2006 - 03/2004
4
Apolipoproteins
IBA
10/2006 - 07/2002
3
Glycated Hemoglobin (Glycosylated Hemoglobin)
IBA
03/2024 - 01/2014
3
Lipids
IBA
03/2024 - 03/2011
3
Insulin Glargine (Lantus)
FDA Link
01/2023 - 06/2018
3
Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
IBA
01/2016 - 07/2002
3
Metformin (Glucophage)
FDA Link
Generic
02/2014 - 05/2013
3
Ligands
IBA
11/2012 - 10/2006
3
Proteins (Proteins, Gene)
FDA Link
11/2009 - 05/2002
3
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
11/2005 - 07/2002
2
Glucagon-Like Peptide 1 (GLP 1)
IBA
03/2024 - 09/2023
2
Glucagon-Like Peptide-1 Receptor
IBA
03/2024 - 11/2023
2
IDegLira
IBA
03/2024 - 03/2021
2
semaglutide
IBA
12/2023 - 09/2023
2
Antihypertensive Agents (Antihypertensives)
IBA
06/2023 - 07/2002
2
omega-Chloroacetophenone (Mace)
IBA
01/2023 - 01/2021
2
lixisenatide
IBA
01/2023 - 03/2021
2
Liraglutide
FDA Link
03/2021 - 01/2018
2
Carbohydrates
IBA
01/2021 - 04/2017
2
Cytokines
IBA
01/2014 - 04/2013
2
Platelet-Derived Growth Factor
IBA
04/2013 - 05/2004
2
Angiotensin II
IBA
03/2011 - 04/2004
2
Streptozocin (Streptozotocin)
FDA Link
10/2006 - 07/2004
2
Connective Tissue Growth Factor
IBA
10/2005 - 07/2002
2
Albumins
IBA
06/2005 - 03/2003
2
Transforming Growth Factor beta1 (TGF beta 1)
IBA
08/2004 - 03/2003
2
alagebrium
IBA
07/2004 - 04/2003
2
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
05/2004 - 03/2004
2
Irbesartan
FDA Link
Generic
03/2004 - 08/2002
1
Cholesterol
IBA
06/2023
1
HDL Cholesterol
IBA
06/2023
1
Creatinine
IBA
01/2023
1
Glycoside Hydrolase Inhibitors
IBA
01/2022
1
Pioglitazone (Actos)
FDA Link
01/2022
1
insulin degludec
IBA
03/2021
1
Sodium
IBA
10/2019
1
Gadolinium
IBA
02/2019
1
Contrast Media
IBA
02/2019
1
Insulin Lispro (Humalog)
FDA Link
06/2018
1
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
01/2016
1
Perindopril
FDA Link
Generic
03/2015
1
Acarbose
FDA Link
Generic
02/2014
1
Hypoglycemic Agents (Hypoglycemics)
IBA
05/2013
1
Interleukin-6 (Interleukin 6)
IBA
04/2013
1
Becaplermin (PDGF-BB)
FDA Link
04/2013
1
TNF-Related Apoptosis-Inducing Ligand
IBA
11/2012
1
candesartan
IBA
03/2011
1
Complement System Proteins (Complement)
IBA
11/2009
1
RANK Ligand
IBA
12/2006
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
10/2006
1
Neprilysin (Neutral Endopeptidase)
IBA
11/2005
1
omapatrilat
IBA
11/2005
1
Messenger RNA (mRNA)
IBA
10/2005
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
10/2005
1
alpha 1 Chain Collagen Type I
IBA
10/2005
Therapy/Procedure
11
Therapeutics
05/2024 - 10/2006
5
Glycemic Control
11/2023 - 03/2002
1
Immunotherapy
04/2024
1
Intravenous Injections
10/2006
1
Intraperitoneal Injections
10/2006